Tg(Ins1-Akt*)138Perm
Transgene Detail
|
|
| Symbol: |
Tg(Ins1-Akt*)138Perm |
| Name: |
transgene insertion 138, M Permutt |
| MGI ID: |
MGI:5318861 |
| Synonyms: |
caAktTg, RIP-Akt |
| Transgene: |
Tg(Ins1-Akt*)138Perm Location: unknown
|
| Alliance: |
Tg(Ins1-Akt*)138Perm page
|
|
| Strain of Origin: |
C57BL/6 x CBA
|
|
| Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: This transgene expressesa constitutively active Akt1 that lacks the PH domain (Aktdelta4-129) and contains an N-terminal Src myristolation signal (myrAktdelta4-129) along with an hemagglutinin (HA) tag for monitoring expression from the rat insulin 1 promoter. Three transgenic founders (no. 167, no. 138, and no. 139) were established.
(J:73141)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
| Original: |
J:73141 Bernal-Mizrachi E, et al., Islet beta cell expression of constitutively active Akt1/PKBalpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest. 2001 Dec;108(11):1631-8 |
| All: |
5 reference(s) |
|